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Replication, transcription, and translation stress all lead to
stalling of their respective polymerases (DNA polymerase,
RNA polymerase, and the ribosome), and the cell must
respond to these events in order to preserve macromolec-
ular integrity. In response to replication stress such as
DNA damage, the cell activates a checkpoint and pro-
motes repair or bypass at the lesion. Transcriptional stress
leading to stalling of RNA polymerase can also be caused
by DNA damage, and recognizing stalled RNA polymerase
can lead to transcription-coupled repair or, in response to
prolonged stalling, degradation of the polymerase. Trans-
lational stress generated by problems either with the
mRNA template or the ribosome itself also leads to stalling
of the ribosome, and the cell responds by degrading both
the message and the nascent polypeptide. In this review,
we will discuss the stresses that lead to stalling of each
of the polymerases and how the cell recognizes and re-
sponds to the stalled enzymes.
Introduction
The central dogma of molecular biology describes the trans-
fer of information from DNA to RNA to protein. The synthesis
of each of these molecules is carried out by a large multi-
subunit polymerase: DNA polymerase, RNA polymerase,
and the ribosome (in this review, wewill include the ribosome
when referring to polymerases in general). In each case,
issues can arise causing these polymerases to inappropri-
ately stall on their respective templates, and the cell must
identify and correct such events to preserve genomic and
macromolecular integrity.
Polymerases can stall for several reasons. First, the
polymerase may attempt to read a damaged template,
blocking its progression. By recognizing the damaged tem-
plate, and promoting the repair or destruction of that tem-
plate, each of the polymerases has a template scanning,
protective function. Alternatively, the polymerase itself can
be damaged or incorrectly assembled, causing it to stall or
create an aberrant product. In addition, barriers on tem-
plates, such as protein complexes or secondary structures,
can also impede the progress of polymerases. Finally, low
nucleotide or amino acid pools cause polymerase stalling.
In each of these cases, cells must distinguish between an
actively replicating polymerase and a stalled polymerase
trying to read or repair a damaged template. One of the least
understood aspects of the response to polymerase stalling is
the actual recognition of this event.
The nature of DNA synthesis, RNA synthesis and transla-
tion places unique restrictions on the ways in which the
cell can correct problems occurring during each phase of
macromolecular synthesis. In the case of DNA or RNA poly-
merase, the template, DNA, must be repaired. For DNA poly-
merase, not only is its substrate essential, but the nascentDepartment of Biochemistry and Biophysics, University of California,
San Francisco, San Francisco, CA 94158, USA.
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that allows replication to be restarted after repair. In
contrast, the product of any single RNA polymerase event
is nonessential. The stalled RNA polymerase itself can be
targeted for destruction, and the DNA template can return
to the ground state after the nascent message and polymer-
ase are removed. During translation, the ribosome, nascent
polypeptide and mRNA are all, in theory, dispensable,
although an effort to conserve resources may restrain the
degree to which these components are degraded. In this re-
view, we will examine the common elements of pathways
that react to each of these situations, as well as contrasts
between them.
DNA Replication
Replication is one of the primary ways that a cell scans its
genome for damage. During replication, DNA polymerase
associates with a large number of auxiliary factors, including
the MCM replicative helicase complex and the sliding clamp
PCNA, to processively move along the DNA. In addition to its
polymerizing activity, this complex coordinates the damage
response by activating the DNA replication checkpoint and
promoting repair. Consistent with a template scanning
role for DNA replication, non-cycling cells do not repair
genome-wide DNA damage as well as cells that are actively
cycling [1]. Moreover, damaging agents such as methyl
methanesulfonate (MMS) generate modified bases that
are largely detected when the polymerase encounters the
lesion [2].
The replication checkpoint is activated at replication forks
stalled by DNA damage, depletion of nucleotide pools (for
instance with ribonucleotide reductase inhibitor hydroxy-
urea (HU)), or inhibition of polymerase itself (with drugs
such as aphidicolin). In addition, replication through some
sequences is inherently problematic for the polymerase.
Loci called common fragile sites (in mammalian cells) or
replication slow zones (in budding yeast) are sensitive to
replication stress and prone to breakage. The stability of
these sites in yeast and mammals requires the DNA replica-
tion checkpoint kinase Mec1/ATR (for this review, homologs
will be referred to by budding yeast/mammalian names),
suggesting that these sites elicit damage after polymerase
stalling during S phase that is recognized by the checkpoint
[3,4]. DNA polymerase can also stall at specific protein
barriers or at highly transcribed genes [5]. Replication
fork barriers (RFBs) in Schizosaccharomyces pombe and
Saccharomyces cerevisiae are composed of DNA binding
proteins that cause unidirectional polymerase stalling
[6,7]. The block at RFBs requires the budding yeast replica-
tion checkpoint proteins Tof1 and Csm3 (Swi1 and Swi3,
respectively, in S. pombe) which associate with MCMs
and move with the fork, suggesting that stably stopping at
RFBs is an active process [8–10]. Stalling at such physical
barriers may differ from stalling at DNA lesions or due to
nucleotide depletion because, in addition to blocking the
polymerase, the MCM helicase is also directly blocked.
Consistent with this notion, stalling at RFBs does not lead
to the accumulation of single-stranded DNA (ssDNA) [11]
and does not require the DNA replication checkpoint
pathway [9,12].
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aspects of cellular metabolism, including halting the cell
cycle and promoting survival [13]. Upon recognition of DNA
damage or polymerase stalling, the replication checkpoint
sensor kinase Mec1/ATR is recruited to sites of stalled poly-
merase and activated. This kinase then phosphorylates and
activates downstream effector kinases, importantly Rad53
(in budding yeast) and Chk1 (in mammals). While forms of
DNA damage that generate large regions of ssDNA are
recognized throughout the cell cycle (such as UV damage
which is processed by nucleotide excision repair machinery
[14]), genotoxic agents that cause damage or stall polymer-
ase and are recognized during S phase rely on the replisome
component Mrc1/Claspin as the adaptor for checkpoint acti-
vation. Mrc1/Claspin associates with Tof1/Timeless and
Csm3/Tipin and directly binds the downstream checkpoint
kinases and promotes their activation.
The signal for activation of the DNA replication checkpoint
is the accumulation of exposed ssDNA coated with the
ssDNA binding protein RPA. In budding yeast, approxi-
mately 200 nucleotides of ssDNA are exposed during normal
replication, whereas forks stalled by HU generate about 320
nucleotides [15]. The additional exposed ssDNA at these
structures distinguishes a stalled fork from ongoing replica-
tion. Importantly, ongoing replication itself does not activate
the canonical checkpoint, and budding yeast cells can enter
anaphase in the presence of actively replicating DNA [16].
RPA-coated ssDNA activates the checkpoint by providing
a template for the co-recruitment of the upstream check-
point kinase Mec1/ATR and its activators [17,18]. Mec1/
ATR is recruited to RPA by its binding partner Ddc2/ATRIP.
The downstream kinase (Rad53 or Chk1) is recruited through
interactions with the mediator Mrc1/Claspin. Highlighting
the importance of increased local protein concentrations
achieved via these recruitment events, forced co-localization
of Mec1/ATR with its activators or with Mrc1/Claspin is suf-
ficient for in vivo checkpoint activation even in the absence of
DNA damage [19,20].
Once the checkpoint is activated, it maintains the replica-
tion competence of stalled forks and prevents the firing of
later origins (Figure 1). Firing of these origins is inhibited
by the checkpoint in both yeast and mammalian cells. In
budding yeast, Rad53 phosphorylates and inhibits replica-
tion initiation factors Dbf4 and Sld3 [21,22], and both the
inhibition of Treslin (the ortholog of Sld3) and the phosphor-
ylation of Dbf4 by checkpoint kinases is conserved in mam-
mals [23,24]. The MCM replicative helicase complex and
associated proteins are also phosphorylated by checkpoint
kinases [25,26]. Although the effects of these particular
phosphorylations are not well understood, Chk2 phosphory-
lation of the MCM helicase complex in flies blocks its
activity [27].
The checkpoint’s most important function has canonically
been thought to be the stabilization of the replication fork
itself — preventing DNA breaks from accumulating by pro-
moting the continued association of polymerase and other
replication factors (called the replisome) with each other
and with the DNA. Recent work, however, suggests that
the replisome is stably maintained at the replication fork
even in the absence of a functional checkpoint [25]. This
study suggests that the checkpoint may primarily function
to maintain the replisome in a replication-competent state
at stalled forks, in order to allow replication to resume once
the challenge has been removed. In yeast, deletion of thenuclease Exo1 can suppress the sensitivity of rad53D mu-
tants to MMS, suggesting that inhibiting Exo1-dependent
processing may be one important checkpoint function
[28,29] (Figure 1). In mammals, HARP/SMARCAL1 is
recruited to sites of DNA damage by a direct interaction
with RPA [30–33], and phosphorylation by the checkpoint
kinase ATR limits its activity [34]. SMARCAL1 is a DNA
annealing helicase that can re-wind ssDNA stably coated
with RPA, as well as perform branch migration and fork
regression [35,36], which suggests that it may be a check-
point target involved in both fork stabilization and replication
restart [30,31,34,37].
An intriguing new study in mammalian cells suggests that
DNA breaks accumulate at a fork following exposure to repli-
cation stress because an excess of ssDNA exhausts the pool
of RPA [38]. The data show that forks are initially stable, even
in the absence of a functional checkpoint, and are prone to
breakage only after RPA pools are exhausted. Moreover,
modulating levels of functional RPA can speed up or slow
down this process. This paper suggests that the checkpoint
inhibition of late origin firing and potentially the inhibition of
the MCM helicase or other targets involved in replication
that limit ssDNA accumulation may indirectly allow the
checkpoint to maintain stable forks for prolonged periods
of time.
The stalled replisome can also directly coordinate repair
through the modification of the sliding clamp PCNA
(Figure 1). In response to DNA damage, PCNA is modified
by ubiquitination. Ubiquitination of PCNA is independent of
the checkpoint, but it is promoted in response to polymerase
stalling by the same upstream signal — accumulation of
RPA-coated ssDNA [39,40]. In this case, Rad6 and Rad18
are recruited to RPA and monoubiquitinate PCNA at lysine
K164 [41]. Monoubiquitination of PCNA promotes bypass
of damage by the translesion polymerases Polh, Polz,
and Rev1 [42,43]. These polymerases have larger active
sites and no proofreading, so they can accommodate
bulky adducts and polymerize across them. Although often
thought of as error-prone, they bypass some DNA lesions
in an error-free way, for instance by adding adenosines
across from thymine dimers. In yeast, monoubiquitination
of PCNA at K164 can be extended by the Ubc13–Mms2
heterodimeric E2 and the Rad5 E3 to generate K63-linked
polyubiquitin chains [41]. Polyubiquitinated PCNA has been
proposed to promote error-free lesion bypass through a
template-switching mechanism. Recent work in mammalian
cells has demonstrated that polyubiquitinated PCNA pro-
motes fork restart through the recruitment of ZRANB3.
ZRANB3 has several biochemical activities — as an anneal-
ing helicase, a translocase, and a structure-specific endonu-
clease — that might allow error-free template bypass, fork
restart, or even, in the case of its endonuclease function,
repair of DNA damage at the fork [44–46]. Mammals have
two Rad5-related enzymes (HLTF and SHPRH). Over-
expression of these enzymes has been shown to promote
polyubiquitination of PCNA [47,48]. However, these enzymes
also coordinate translesion synthesis, and HLTF promotes
monoubiquitination of PCNA [49]. The precise mechanism
of polymerase switching from the processive replicative
polymerases to translesion polymerases is still unknown,
though translesion synthesis can occur without bulk DNA
replication [50]. A recent paper suggests a model for the
polymerase switch by showing that the catalytic subunit of
the lagging strand polymerase (Pol3, part of polymerase d)
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Figure 1. Polymerases coordinate the re-
sponse to stalling.
When DNA polymerase (top, depicted in blue)
stalls, ATR is recruited to RPA-coated single-
stranded DNA (ssDNA). ATR then phosphory-
lates and activates Rad53 (yeast) or Chk1
(humans), which goes on to phosphorylate
downstream targets including Dbf4 and
Sld3/Treslin to inhibit new origin firing, and,
potentially, Exo1. RPA-coated ssDNA can
also recruit Rad18–Rad6 to monoubiquitinate
PCNA, which promotes association of transle-
sion polymerases (TLS Pol, depicted in teal).
Rad5-dependent polyubiquitination of PCNA
promotes error-free lesion bypass by a tem-
plate-switching mechanism. RNA polymerase
(middle, depicted in fuchsia) stalling can pro-
mote transcription-coupled repair by back-
tracking and recruiting Rad26/CSB and TFIIH.
Alternatively, after prolonged stalling, RNA
polymerase can be degraded as amechanism
of last resort. Def1 is processed in the
cytoplasm following monoubiquitination by
Rsp5, which allows Def1 to accumulate in
the nucleus. Def1 then recruits an Elongin–
Cullin E3 ligase to polyubiquitinate RNA
polymerase II to promote its degradation.
Stalling of ribosomes (bottom, shown in red)
leads to Hbs1 and Dom34/Pelota promoting
dissociation of the ribosome and an endonu-
clealytic cleavage of the mRNA, which is
then fully degraded by exonucleases Xrn1
and the exosome. Ltn1 then associates with
the large subunit and ubiquitinates the
nascent polypeptide to target it for degrada-
tion. Polyubiquitin chains depicted in green
reflect degradative chains, while polyubiquitin
chains depicted in purple are non-degrada-
tive, K63-linked chains.
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R447is degraded in response to DNA dam-
age [51], which may allow translesion
polymerase Rev1 to interact with the
non-catalytic subunits of polymerase
d. Interestingly, the process of poly-
merase degradation requires Def1,
which associates with Rad5 [51] and
is known to promote the degradation
of RNA polymerase (discussed below). These data seem to
contradict other work suggesting that the replisome is stable
following replication stress [25]. In trying to reconcile these
recent papers, we note that replisome stability was shown
with leading strand polymerase (Pol ε) rather than Pol d.
The two papers also use different agents to stall replication,
and the degradation of Pol3 was never shown to occur at
stalled replication forks themselves.
Transcription
RNA polymerase responds to the same lesions on the same
template as DNA polymerase. In fact, stalling of transcrip-
tion by various means can result in RPA- and ATR-depen-
dent phosphorylation of p53, suggesting activation of
the checkpoint [52]. An elongating RNA polymerase will
not stall at all DNA lesions, but is particularly susceptible
to pausing at bulky DNA adducts, such as cisplatin-induced
crosslinks, and UV-induced photoproducts, such as
thymine dimers [53]. Detailed structural work has providedclues as to how RNA polymerase stalls at different DNA
lesions. Cisplatin-induced DNA damage generates a con-
formational change in the template strand that prevents
the lesion from entering the RNA polymerase II active site
[54]. In contrast, a thymine dimer can enter the active site,
and subsequent stalling depends on which ribonucleotide
is inserted to base-pair with the lesion [55]. Similar to trans-
lesion DNA polymerases, transcription machinery preferen-
tially inserts adenylate across from these sites, which is
error-free and does not result in stalling. Instead, stalling
in this situation only occurs when a uridylate nucleotide is
mis-incorporated [55,56]. More work is needed to know
whether these examples represent two common modes
of polymerase stalling or whether other lesions stall RNA
polymerase by distinct mechanisms. Also, it will be impor-
tant to determine whether the mechanisms of RNA polymer-
ase stalling described in these studies, which have been
done on naked DNA, are affected by DNA binding proteins
such as nucleosomes or RPA. Lesions that are bypassed
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canonical repair machinery or recognized by the stalling of
DNA polymerase during replication. While the mechanisms
promoting trans-lesion RNA synthesis at thymine dimers
and other lesions remain poorly understood, it is clear that
bypass can be important for cell survival after DNA damage,
albeit increasing transcription-associated mutagenesis
under some circumstances [56].
Similar to DNA polymerase, RNA polymerase stalling can
lead to lesion processing and DNA repair [57] in a process
called transcription-coupled repair (TCR). TCR was first
described almost three decades ago [58,59] and is largely
studied in the context of thymine dimers and other lesions
caused by UV, as these lesions can stall RNA polymerase
for prolonged periods of time. One result of TCR is that
lesions in the template DNA strand are repaired with
increased efficiency relative to those occurring in the non-
transcribed strand [60].
A key question in TCR is how repair machinery gains
access to the DNA lesion, which may be obstructed by
RNA polymerase enzyme. In eukaryotic cells, only RNA
polymerase I has been observed to be released from sites
of DNA damage encountered during transcription [61], and
this phenomenon is poorly understood. Instead, eukaryotic
RNA polymerase II backtracks along DNA to facilitate endo-
nuclease access [62]. A recent study [63] suggests that
backtracking may also play a role in providing access to
repair machinery in bacteria, although prokaryotic RNA
polymerase can also be released altogether [64]. Back-
tracked eukaryotic RNA polymerase itself cleaves the tran-
script to allow its realignment with the polymerase active
site. This cleavage activity is stimulated by TFIIS and is
required for viability in yeast [65].
In many ways, TCR is very similar to nucleotide excision
repair (NER), which recognizes the same lesions through
direct recognition of structural aberrations in the DNA tem-
plate. In both pathways, recruitment of TFIIH to damage sites
provides a scaffold that directs the XRCCI and XPA nucle-
ases to excise the lesion along with short stretches of
surrounding sequence (Figure 1). During TCR, the first
responder, Rad26/CSB, recruits TFIIH. HowRad26/CSB rec-
ognizes a stalled RNA polymerase to signal the presence of a
DNA lesion is unclear [62]. Some evidence suggests that
Rad26/CSB may transiently associate with RNA polymerase
II during transcriptional elongation and that prolonged stall-
ing triggers a more stable interaction [66]. In mammalian
cells, the CSA protein, which has E3 ubiquitin ligase activity,
is also required for scaffold assembly. A ubiquitin binding
domain on CSB is required for TCR in mammalian cells,
despite the proficient recruitment of lesion processing
machineries to sites of stalled RNA polymerase II in its
absence [67]. These data suggest that recruitment of repair
factors to DNA lesions may not be enough to trigger DNA
repair and that a second, as yet unknown, signal is required
to initiate the process. Whether this unknown signal also
recognizes stalled polymerase is still unknown. Mutations
in CSA and CSB give rise to Cockayne syndrome, a disease
characterized by sensitivity to UV light, progressive defects
in neurological development and premature aging. These
phenotypes differ from those associated with global defects
in NER, and this, and other recent work, suggests that
Cockayne-related phenotypes stem from deficiencies in
transcribing specific genes rather than from a global defect
in DNA repair (reviewed in [62,68]).RNA polymerase II itself can be degraded by the ubiquitin–
proteasome system as a mechanism of last resort in
response to prolonged stalling [69] (Figure 1). Ubiquitination
of the largest RNA polymerase II subunit, Rpb1, is a two-step
process [70]. Monoubiquitination, catalyzed by the Rsp5 E3
ubiquitin ligase (NEDD4 in humans) [71], occurs at significant
levels even in the absence of DNA damage or transcriptional
stress [69,72]. Prolonged transcriptional pausing leads to the
extension of this monoubiquitin mark to K48-linked polyubi-
quitin chains that signal RNA polymerase II for degradation.
The polyubiquitination of RNA polymerase II occurs via an
Elongin–Cullin E3 ligase containing Elc1, Ela1, and Cul3,
which is recruited to the stalled polymerase by the Rpb1-
binding protein Def1. Elegant work from the Svejstrup lab
has shown that an amino-terminal CUE domain in the Def1
protein binds to a ubiquitin homology domain on Ela1 to
facilitate association of the Elongin–Cullin complex with
Rpb1 [73].
How does Def1 specifically recognize stalled RNA poly-
merase II rather than molecules that have initiated transcrip-
tion but remain poised for elongation downstream of
transcription start sites? Selection of Rpb1 as a substrate
depends on its carboxy-terminal domain (CTD). The RNA
polymerase II CTD includes 26 repeats of a heptapeptide
sequence in yeast and 52 such repeats in humans. The phos-
phorylation pattern of the CTD provides a molecular signa-
ture for polymerase molecules during the initiation and
elongation phases of transcription. In yeast, RNA polymer-
ase II ubiquitination has been shown to be negatively
regulated by CTD phosphorylated on serine 5 of its hepta-
peptide repeats [74], which is characteristic of promter-
associated polymerases [75]. In contrast, the human Elongin
complex has been suggested to selectively target RNA poly-
merase II with serine 5 phosphorylated [76]. As suggested
previously, perhaps other post-translational modifications
on the CTD distinguish between elongating polymerases
that have stalled and initiated polymerases intentionally
poised downstream of the transcription start site [69]. It is
noteworthy, for example, that the terminal CTD repeats on
human Rpb1 have been found to be acetylated [77].
Confining Rpb1 ubiquitination to obstructed polymerases,
rather than elongating polymerases, seems to be regulated
by Def1 itself. Def1 cycles between the nucleus and the
cytoplasm, and its nuclear retention is promoted by a protea-
some-mediated cleavage event that removes a carboxy-
terminal nuclear export signal [73]. Treatment with agents
causing DNA damage or inhibitors of transcription elonga-
tion leads to rapid Def1 processing, which is dependent on
monoubiquitination of Def1 by Rsp5, the same ligase that
targets Rpb1 [73]. The signals that direct this event remain
unclear. The deubiquitinating enzyme Ubp2, which binds to
Rsp5 in vivo and is involved in regulating Rpb1 ubiquitination
[78], can inhibit the accumulation of monoubiquitinated Def1
in vitro, possibly through the direct inhibition of Rsp5 activity
[79,80]. It is tempting to speculate that prolonged stalling of
transcription machineries may somehow inhibit Ubp2 activ-
ity, and thus promote Rsp5 function. Def1 also interacts with
Rad26 [81], suggesting that factors involved in TCR could
promote Rpb1 degradation if repair cannot occur. Regard-
less, much like the events that function to recruit repair pro-
teins following an interruption to DNA replication, ubiquitin
signaling cascades play an essential and complex role
in mediating the response to prolonged stalling of RNA
polymerase.
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Unlike replication and transcription, in the case of protein
biosynthesis, the mRNA template, the protein product, and
the polymerase (ribosome) can all be subject to degradation.
Translation can be disrupted bymany of the same things that
disrupt DNA replication and transcription. As with low nucle-
otide pools during replication and transcription, low amino
acid levels stall translation. This is best characterized in pro-
karyotes, where, during attenuation (in the case of specific
operons) or the stringent response, ribosome stalling signals
changes in gene expression [82]. Moreover, many agents
that induceDNA damage can also alter RNA, and this directly
affects translation. Human cells treated with damaging
agents or transfected with in vitro oxidized mRNA generate
carboxy-terminally truncated translation products [83].
These likely arise when ribosomes stall, and the translation
products themselves are thought to be targeted for degrada-
tion by ubiquitination, as they accumulate to high levels
when the proteasome is inhibited. While enzymes that repair
RNA have been described, many damaged templates are
likely destroyed.
Problems in translation can also arise on templates as a
result of the sequences of the mRNAs themselves. This
can take the form of errors in splicing or polyadenylation,
mRNA truncation, transcriptional errors, or aspects intrinsic
to the sequence, such as polyA stretches or a propensity
to form secondary structures. In each of these cases, both
the mRNA template and the nascent protein product are
targeted for degradation. Three pathways have been
described to recognize these mRNAs and nascent proteins
depending upon the nature of the template problem:
nonsense-mediated decay (NMD), no go decay (NGD) and
non-stop decay (NSD) [84]. NMD is the outlier of these in
that translation, per se, is not inherently problematic.
Instead, NMD targets situations in which the open reading
frame encoded by the mRNA is prematurely ended. NMD
is triggered when a termination event occurs upstream of
the last exon junction (as recognized by the existence of
the exon junction complex) and by othermore poorly charac-
terized features. While this recognition was first believed
to take place in the initial pioneer round [85], more recent
studies suggest that it may also occur during subsequent
rounds of translation [86]. Either way, it appears that, similar
to replication and transcription, translation provides a
template-scanning role.
While initially thought to be distinct, NGD and NSD appear
to be highly related mechanistically. NSD occurs when no
termination codon exists and translation extends into the
poly A tail, which codes polylysine and leads to ribosome
stalling [87,88]. NGD is triggered by the direct pausing of
the ribosome [89]. This can be due to a strong secondary
structure in the message, by a truncated mRNA, or by
some sequence elements, such as moderately long
stretches of basic residues within the open reading frame
as would be encountered upon translation of the poly A
tail. As a consequence of ribosome stalling, the mRNA is
targeted for degradation. Dom34/Pelota and Hbs1, which
facilitate the degradation of the mRNA, are related to the
translation release factors eRF1 and eRF3, respectively,
and, analogously, bind to the ribosomal A site [89–91].
Dom34/Pelota and Hbs1 promote an endonucleolytic cleav-
age of themRNA, which is then fully degraded by two exonu-
cleases: Xrn1 and a nuclease complex called the exosome
[84] (Figure 1).Meanwhile, the nascent polypeptide that is generated dur-
ing NGD and NSD is also targeted for degradation by ubiqui-
tination through the action of a ubiquitin ligase called Listerin
(Ltn1) [92]. Ltn1, together with two other factors, Tae2 and
Rqc1, forms a complex that recognizes stalled ribosomes
during NSD and NGD [92–94]. Hbs1 promotes the dissocia-
tion of stalled 80S ribosomes into 60S and 40S subunits
[95–97]. Because Ltn1 appears to bind specifically to the
60S ribosomal subunit associated with the nascent peptide
(as opposed to the intact 80S ribosome), elimination of
Hbs1 blocks the binding of Ltn1 and the subsequent ubiqui-
tination of the nascent peptide [98]. The Ltn1 complex also
interacts with Cdc48, an AAA ATPase which binds and ex-
tracts ubiquitinated substrates from macromolecular com-
plexes, and is therefore likely involved in fully removing the
ubiquitinated nascent peptide to enable its destruction by
the proteasome [93,94]. Together, these recent findings
allow us to start to form a model for the way in which stalled
ribosomes are processed, but we are still left without an
explanation as to how they are recognized in the first place.
Most analyses of stalled ribosomes have examined stall-
ing occurring due to issues with the template; however,
defective ribosomes can also be a source of translational
stress. While this could, in theory, be due to misfolding,
loss or damage of ribosomal proteins, most of the experi-
ments examining this phenomenon thus far have investi-
gated the effects of mutated or incorrectly processed
rRNA. rRNA quality control is monitored quite closely. Inacti-
vating point mutations in 18S rRNA result in its instability.
Both mutant 18S rRNA and NGD intermediates are localized
to P bodies, and the instability of the mutant 18S rRNA re-
quires active translation and genes that also function in
NGD, such as DOM34 [99]. This suggests that ribosomes
containing defective 18S rRNAs stall and are recognized by
similar machineries that recognize functional ribosomes
that are stalled on aberrant messages. The final steps in pro-
cessing of the 18S rRNAof the 40S subunit are preceded by a
faux translation cycle in which the incomplete 40S and 60S
form a translation-incompetent 80S-like particle, which is
subsequently dissociated, helping to ensure that the 40S
particle is properly assembled [100]. Surprisingly, ribosomes
with mutant 25S rRNA (the yeast 28S) appear to be recog-
nized and targeted by a distinct, more poorly understood,
pathway [101].
Conclusions
A number of common themes arise during the cellular re-
sponses to stalling during replication, transcription and
translation. First, stalling of all three polymerase enzymes
can be triggered by structural aberrations of the nucleic
acid template. In addition, depletion of building blocks
(dNTPs, NTPs, or amino acids) can stall polymerases. Since
both DNA and RNA polymerase read the same template,
these two polymerases have the most similarities, with
stalled RNA polymerase even being capable of activating a
checkpoint response [52]. In addition, RNA polymerase
backtracking at sites of damage may allow transcriptional
restart, similar to replication fork reversal at sites of stalled
DNA polymerases [102].
Ubiquitin signaling cascades play a particularly important
role at stalled DNA and RNA polymerases. In both cases,
these signaling cascades are activated directly at the sites
of stalling and recruit repair machinery, and may therefore
limit signaling for repair to the lesion itself. Beyond its role
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polymerases for destruction. Importantly, the recent discov-
ery that Def1 may play a role in mediating DNA polymerase
ubiquitination after replication stress, in addition to its estab-
lished role in targeting stalled RNA polymerase for destruc-
tion, suggests that stress may activate a common set of
mediators. Other signaling proteins may also be shared
between stalled DNA polymerase and stalled RNA polymer-
ase. Recently, PRP19, a factor known to normally interact
with RNA polymerase during unperturbed transcription
[103,104], was found to promote ATR signaling in mamma-
lian cells in response to DNA damage [105]. Perhaps this pro-
tein is also required for the cellular response to stalled RNA
polymerase.
Finally, for RNA and DNA polymerases that stall at sites of
DNA damage, it is noteworthy that repair of the lesion itself is
not sufficient to allow resumption of transcription or replica-
tion. In the case of DNA replication, chromatin structure and
nucleosome re-assembly may be involved, and K56 acetyla-
tion on histone H3 is required [106]. In addition, turning off
the checkpoint is itself an active process. Because of
the broad cellular consequences of checkpoint activation,
including the canonical effects on cell cycle progression, re-
covery is likely an obligatorily global phenomenon, involving
dephosphorylation of checkpoint targets by several phos-
phatases. Transcriptional restart also appears to be an
active, albeit poorly characterized, process. Intriguing work
from the Almouzni group suggests that in mammals, tran-
scription restart may be primed by the deposition of an H3
histone variant [107]. In yeast, the FACT nucleosome remod-
eling complexmay play an analogous role by regulating H2A/
H2B deposition near stalled RNA polymerases [108]. In the
case of transcription, the influence of chromatin may be
very local. Although dissociated ribosomes released from
their problematic templates would be free to re-initiate trans-
lation at any message, ribosome restart on the same tem-
plate after stalling has not been characterized. Future work
will be required to have a better mechanistic understanding
of these processes.
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